MEP20908A - Thienopyrazoles - Google Patents

Thienopyrazoles

Info

Publication number
MEP20908A
MEP20908A MEP-209/08A MEP20908A MEP20908A ME P20908 A MEP20908 A ME P20908A ME P20908 A MEP20908 A ME P20908A ME P20908 A MEP20908 A ME P20908A
Authority
ME
Montenegro
Prior art keywords
thienopyrazoles
altered
inhibition
compounds
preparation
Prior art date
Application number
MEP-209/08A
Other languages
Bosnian (bs)
English (en)
Unknown language (me)
Inventor
John Gerard Jurcak
Matthieu Barrague
Timothy Alan Gillespy
Michael Louis Edwards
Kwon Yon Musick
Philip Marvin Weintraub
Yan Du
Ramalinga M Dharanipragada
Ashfaq Ahmed Parkar
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of MEP20908A publication Critical patent/MEP20908A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MEP-209/08A 2003-09-08 2004-07-23 Thienopyrazoles MEP20908A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50115903P 2003-09-08 2003-09-08
PCT/US2004/023814 WO2005026175A1 (en) 2003-09-08 2004-07-23 Thienopyrazoles

Publications (1)

Publication Number Publication Date
MEP20908A true MEP20908A (en) 2010-06-10

Family

ID=34312256

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-209/08A MEP20908A (en) 2003-09-08 2004-07-23 Thienopyrazoles

Country Status (29)

Country Link
US (2) US7518000B2 (sr)
JP (1) JP4879739B2 (sr)
KR (1) KR20060069490A (sr)
CN (1) CN100398545C (sr)
AT (1) ATE468341T1 (sr)
AU (1) AU2004272507B2 (sr)
BR (1) BRPI0414215A (sr)
CA (1) CA2538032C (sr)
CR (1) CR8255A (sr)
DE (1) DE602004027288D1 (sr)
DK (1) DK1682553T3 (sr)
EC (1) ECSP066411A (sr)
ES (1) ES2345257T3 (sr)
HR (1) HRP20100398T1 (sr)
IL (1) IL173916A (sr)
MA (1) MA28038A1 (sr)
ME (1) MEP20908A (sr)
MX (1) MXPA06001827A (sr)
MY (1) MY144339A (sr)
NO (1) NO20061626L (sr)
NZ (1) NZ545421A (sr)
OA (1) OA13252A (sr)
PT (1) PT1682553E (sr)
RS (2) RS51846B (sr)
RU (1) RU2358978C2 (sr)
TN (1) TNSN06058A1 (sr)
TW (1) TWI352705B (sr)
WO (1) WO2005026175A1 (sr)
ZA (1) ZA200601947B (sr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006101454A1 (en) * 2005-03-21 2006-09-28 S*Bio Pte Ltd Benzothiophene derivatives: preparation and pharmaceutical applications
WO2007076228A2 (en) * 2005-12-20 2007-07-05 Boehringer Ingelheim International Gmbh 2-(ih-thieno [3,2-c] pyrazol-3yl)-ih-indole derivatives and related compounds as tec kinase inhibitors for the treatment of inflammations and immunological disorders
EP2151433A1 (en) 2008-08-05 2010-02-10 Institut Pasteur Alkoxypyrazoles and the process for their preparation
EP2151434A1 (en) 2008-08-05 2010-02-10 Institut Pasteur Alkoxypyrazoles and the process for their preparation
US8299070B2 (en) * 2009-11-25 2012-10-30 Japan Tobacco Inc. Indole compounds and pharmaceutical use thereof
US20130158066A1 (en) * 2011-12-20 2013-06-20 Hoffmann-La Roche Inc. 4-azaindole inhibitors of crac
WO2013153539A1 (en) 2012-04-13 2013-10-17 Glenmark Pharmaceuticals S.A. Tricyclic compounds as tec kinase inhibitors
CN103467481B (zh) * 2012-06-07 2016-08-31 上海汇伦生命科技有限公司 二氢吡啶类化合物、其组合物、制备方法和用途
TW201414734A (zh) 2012-07-10 2014-04-16 Takeda Pharmaceutical 氮雜吲哚衍生物
WO2014041518A1 (en) * 2012-09-14 2014-03-20 Glenmark Pharmaceuticals S.A. Thienopyrrole derivatives as itk inhibitors
CN103720694A (zh) * 2012-10-11 2014-04-16 韩冰 一类治疗脑性瘫痪的化合物及其用途
CN103772391A (zh) * 2012-10-23 2014-05-07 杨子娇 一类治疗房角狭窄的化合物及其用途
KR101571590B1 (ko) * 2012-11-21 2015-11-25 주식회사 두산 유기 화합물 및 이를 이용하는 유기 전계 발광 소자
JP2016538270A (ja) 2013-10-25 2016-12-08 ファーマサイクリックス エルエルシー 移植片対宿主病を処置し予防する方法
WO2015106012A1 (en) 2014-01-09 2015-07-16 Takeda Pharmaceutical Company Limited Azaindole derivatives
WO2016010108A1 (ja) * 2014-07-18 2016-01-21 塩野義製薬株式会社 含窒素複素環誘導体およびそれらを含有する医薬組成物
MA45973A (fr) 2015-08-31 2019-06-26 Pharmacyclics Llc Combinaisons d'inhibiteurs de btk pour le traitement du myélome multiple
JP2019532997A (ja) 2016-11-03 2019-11-14 ジュノー セラピューティクス インコーポレイテッド Ｔ細胞療法とｂｔｋ阻害剤との併用療法
KR20210044736A (ko) 2018-05-03 2021-04-23 주노 쎄러퓨티크스 인코퍼레이티드 키메라 항원 수용체(ｃａｒ) ｔ세포 요법과 키나제 억제제의 조합요법
WO2023139248A1 (en) * 2022-01-21 2023-07-27 Ecole Polytechnique Federale De Lausanne (Epfl) Inhibitors of acyl protein thioesterases against microbial infections
WO2023220655A1 (en) 2022-05-11 2023-11-16 Celgene Corporation Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy
WO2024123175A1 (en) 2022-12-06 2024-06-13 Erasmus University Medical Center Rotterdam Compositions for treating immune checkpoint blockade therapy resistant cancers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654307A (en) * 1994-01-25 1997-08-05 Warner-Lambert Company Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
US6462036B1 (en) * 1998-11-06 2002-10-08 Basf Aktiengesellschaft Tricyclic pyrazole derivatives
US6297238B1 (en) * 1999-04-06 2001-10-02 Basf Aktiengesellschaft Therapeutic agents
DK1194425T3 (da) * 1999-06-23 2005-11-21 Aventis Pharma Gmbh Substituerede benzimidazoler
YU54202A (sh) * 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
WO2003024969A1 (en) * 2001-09-14 2003-03-27 Merck & Co., Inc. Tyrosine kinase inhibitors
FR2831536A1 (fr) * 2001-10-26 2003-05-02 Aventis Pharma Sa Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
BR0213562A (pt) * 2001-10-26 2004-08-31 Aventis Pharma Inc Benzimidazóis e análogos e seu uso como inibidores de cinases de proteìna

Also Published As

Publication number Publication date
MXPA06001827A (es) 2006-05-31
RS51846B (sr) 2012-02-29
ATE468341T1 (de) 2010-06-15
RU2006111470A (ru) 2007-10-27
BRPI0414215A (pt) 2006-11-07
CN100398545C (zh) 2008-07-02
CR8255A (es) 2006-07-14
US20070254937A1 (en) 2007-11-01
AU2004272507B2 (en) 2011-05-12
DK1682553T3 (da) 2010-08-23
CN1849322A (zh) 2006-10-18
US7928231B2 (en) 2011-04-19
TW200519118A (en) 2005-06-16
AU2004272507A1 (en) 2005-03-24
ES2345257T3 (es) 2010-09-20
US20100056514A1 (en) 2010-03-04
NZ545421A (en) 2010-03-26
ECSP066411A (es) 2006-09-18
CA2538032A1 (en) 2005-03-24
JP2007505038A (ja) 2007-03-08
IL173916A (en) 2011-07-31
OA13252A (en) 2007-01-31
HRP20100398T1 (hr) 2010-09-30
JP4879739B2 (ja) 2012-02-22
HK1095587A1 (zh) 2007-05-11
KR20060069490A (ko) 2006-06-21
NO20061626L (no) 2006-04-10
WO2005026175A1 (en) 2005-03-24
DE602004027288D1 (en) 2010-07-01
ZA200601947B (en) 2007-05-30
TNSN06058A1 (en) 2007-10-03
RS20060162A (sr) 2008-06-05
TWI352705B (en) 2011-11-21
RU2358978C2 (ru) 2009-06-20
MY144339A (en) 2011-08-29
PT1682553E (pt) 2010-07-29
CA2538032C (en) 2011-01-11
MA28038A1 (fr) 2006-07-03
IL173916A0 (en) 2006-07-05
US7518000B2 (en) 2009-04-14

Similar Documents

Publication Publication Date Title
MEP20908A (en) Thienopyrazoles
CY1122336T1 (el) Eνωσεις πυρρολιου ως αναστολεις πρωτεϊνικων κινασων εrκ και φαρμακευτικες συνθεσεις που περιεχουν αυτες τις ενωσεις
ATE466580T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE365733T1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
DE602006004844D1 (de) Pyrrolopyrimidine verwendbar als protein kinase inhibitoren
ATE450530T1 (de) Zusammensetzungen zur verwendung als protein- kinase-inhibitoren
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
CY1111599T1 (el) Αναστολεις κινασης θειενοπυριδινης και φουροπυριδινης
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
PT1347971E (pt) Inibidores tiazolilicos de tirosina-cinases da familia tec
BRPI0509369A (pt) azaindóis úteis como inibidores de jak e outras proteìna cinases
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
EA200700886A1 (ru) Соединение тиадиазола и его применение
EE200300475A (et) Türosiini kinaasi inhibiitorid, neid sisaldavad ravimkoostised ja nimetatud ühendid kasutamiseks haiguste ravis
NO20082508L (no) Aminopyrimidiner anvendelige som kinaseinhibitorer
NO20071875L (no) Bicykliske amider som kinaseinhibitorer
HRP20050967A2 (en) Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
ATE482213T1 (de) Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine
HRP20050826B1 (hr) Ciklički inhibitori proteinske tirozin kinaze
BRPI0416801A (pt) derivados de 1h-imidazoquinolina como inibidores de proteìna sinase
DE602005020611D1 (de) Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen
ATE377597T1 (de) Anilinochinazoline als protein-tyrosin- kinasehemmer
ATE548363T1 (de) 3,5-disubstituierte pyrid-2-one, die sich als inhibitoren der tec-familie von nicht-rezeptor- tyrosinkinasen eignen
CL2008000021A1 (es) Compuestos derivados de 2,4-dianilinopirimidinas, inhibidores de proteinas cinasas; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades inflamatorias, diabetes y cancer.
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico